Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | C5AR1 | P21730 | 1/20 | 0.65 |
| ▸ | CA12 | O43570 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | TEAD1 | P28347 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.46 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.46 |
| ▸ | HTR6 | P50406 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7150548 | 0.89 | C5AR1 (0.83) | C5AR1CA12CA9GAALMNA | |
| SCHEMBL15756100 | 0.86 | C5AR1 (0.62) | C5AR1CA12CA9LMNATSHR | |
| SCHEMBL17174226 | 0.86 | C5AR1 (0.62) | C5AR1CA12CA9LMNATSHR | |
| SCHEMBL17174236 | 0.86 | C5AR1 (0.62) | C5AR1CA12CA9GAALMNA | |
| SCHEMBL25920653 | 0.86 | C5AR1 (0.62) | C5AR1CA12CA9LMNATSHR | |
| SCHEMBL17174232 | 0.83 | KEAP1 (0.70) | C5AR1LMNAKEAP1KMT2A | |
| SCHEMBL5853978 | 0.82 | TEAD1 (0.49) | C5AR1CA12CA9TEAD1HTR6 | |
| SCHEMBL17174225 | 0.82 | C5AR1 (0.57) | C5AR1CA12CA9LMNATSHR | |
| SCHEMBL17174229 | 0.82 | C5AR1 (0.57) | C5AR1CA12CA9LMNATSHR | |
| SCHEMBL17174230 | 0.80 | RAB9A (0.58) | C5AR1LMNAHTR6NPSR1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118184520-A | Biphenyl amine compound, preparation method thereof and application thereof in flow battery | 中国科学院大连化学物理研究所 | 2024-06-14 | — | — | CN | claimed |
| EP-2838533-B1 | COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY | UNIV CASE WESTERN RESERVE (US) | 2017-10-04 | — | — | EP | disclosed |
| US-20150291517-A1 | BENZENESULFONAMIDE COMPOUNDS FOR SOMATIC EMBRYOGENESIS IN PLANTS | STICHTING DIENST LANDBOUWKUNDIG ONDERZOEK (NL) | 2015-10-15 | — | — | US | disclosed |
| US-20150291517-A1 | BENZENESULFONAMIDE COMPOUNDS FOR SOMATIC EMBRYOGENESIS IN PLANTS | STICHTING DIENST LANDBOUWKUNDIG ONDERZOEK (NL) | 2015-10-15 | — | — | US | disclosed |
| US-8502937-B2 | Protective film for polarizers | FUJIFILM CORPORATION (JP) | 2013-08-06 | — | — | US | disclosed |
| US-8502937-B2 | Protective film for polarizers | FUJIFILM CORPORATION (JP) | 2013-08-06 | — | — | US | disclosed |
| US-20090244705-A1 | PROTECTIVE FILM FOR POLARIZERS | FUJIFILM CORPORATION (JP) | 2009-10-01 | — | — | US | disclosed |
| US-20090244705-A1 | PROTECTIVE FILM FOR POLARIZERS | FUJIFILM CORPORATION (JP) | 2009-10-01 | — | — | US | disclosed |
| US-20090096963-A1 | CYCLIC POLYOLEFIN FILM, PROCESS FOR PRODUCING THE FILM, AND POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME | FUJIFILM CORPORATION (JP) | 2009-04-16 | — | — | US | disclosed |
| US-20090096963-A1 | CYCLIC POLYOLEFIN FILM, PROCESS FOR PRODUCING THE FILM, AND POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME | FUJIFILM CORPORATION (JP) | 2009-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150291517-A1 | BENZENESULFONAMIDE COMPOUNDS FOR SOMATIC EMBRYOGENESIS IN PLANTS | KCNJ2, HCN2, HACL2 | C5AR1 4657/4885CA12 3085/4885CA9 3523/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.